As of April 2024 iRadimed has a market cap of $0.53 Billion. This makes iRadimed the world's 5887th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.53 B | -10.18% |
2023 | $0.59 B | 68.32% |
2022 | $0.35 B | -38.67% |
2021 | $0.57 B | 106.55% |
2020 | $0.28 B | 2.02% |
2019 | $0.27 B | 2.34% |
2018 | $0.26 B | 68.09% |
2017 | $0.15 B | 34.49% |
2016 | $0.11 B | -62.04% |
2015 | $0.31 B | 124.53% |
2014 | $0.13 B |
On Apr 24th, 2024 the market cap of iRadimed was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | $53.33 B | 9,823.70% | ๐บ๐ธ USA |
NuVasive NUVA | $2.08 B | 287.90% | ๐บ๐ธ USA |
DexCom DXCM | $54.60 B | 10,058.75% | ๐บ๐ธ USA |
AtriCure ATRC | $1.11 B | 108.36% | ๐บ๐ธ USA |